Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: relevance to WHO antiretroviral guidelines.
about
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsules
P2860
Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: relevance to WHO antiretroviral guidelines.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@en
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@nl
type
label
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@en
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@nl
prefLabel
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@en
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@nl
P2093
P921
P1433
P1476
Instability of lopinavir/riton ...... WHO antiretroviral guidelines.
@en
P2093
Alice K Pau
Diane T Holland
Edmund V Capparelli
Gugu U Matchaba
Henry Fomundam
Neelambal K Moodley
P304
P356
10.1097/01.AIDS.0000176227.01850.9E
P407
P577
2005-07-01T00:00:00Z